Teva- Pharmaceutical Industries Ltd. ADR’s recent filing unveils that its EVP, Head of U.S. Commercial Fox Christine unloaded Company’s shares for reported $0.33 million on Nov 20 ’24. In the deal valued at $16.87 per share,19,388 shares were sold. As a result of this transaction, Fox Christine now holds 44,104 shares worth roughly $0.73 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, Fox Christine bought 19,388 shares, generating $327,085 in total proceeds.
Before that, Daniell Richard sold 98,943 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $1,711,447 were divested by the Exec. VP, European Commercial at a price of $17.30 per share. As a result of the transaction, Daniell Richard now holds 0 shares, worth roughly $0.0.
Argus upgraded its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to a Buy from a a Hold in a research note published recently. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in early March from “an Underweight” to “a Neutral”. Piper Sandler also remained covering TEVA and has increased its forecast on February 12, 2024 with a “an Overweight” recommendation from previously “Neutral” rating. Jefferies revised its rating on January 23, 2024. It rated TEVA as “a Buy” which previously was an “a Hold”.
Price Performance Review of TEVA
On Monday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock fall -0.77% to $16.65. Over the last five days, the stock has lost -2.75%. Teva- Pharmaceutical Industries Ltd. ADR shares have risen nearly 59.48% since the year began. Nevertheless, the stocks have risen 69.55% over the past one year. While a 52-week high of $19.31 was reached on 11/06/24, a 52-week low of $9.35 was recorded on 01/02/24. SMA at 50 days reached $17.56, while 200 days put it at $16.27.
Levels Of Support And Resistance For TEVA Stock
The 24-hour chart illustrates a support level at 16.52, which if violated will result in even more drops to 16.40. On the upside, there is a resistance level at 16.82. A further resistance level may holdings at 17.00. The Relative Strength Index (RSI) on the 14-day chart is 39.98, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.12, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 62.96%. Stochastics %K at 38.08% indicates the stock is a holding.
How much short interest is there in Teva- Pharmaceutical Industries Ltd. ADR?
A steep rise in short interest was recorded in Teva- Pharmaceutical Industries Ltd. ADR stocks on 2024-11-15, growing by 1.28 million shares to a total of 21.19 million shares. Yahoo Finance data shows the prior-month short interest on 2024-10-15 was 19.91 million shares. There was a rise of 6.05%, which implies that there is a positive sentiment for the stock.
